Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03097601
What this trial is testing

ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to Sunitinib

Who this might be right for
Metastatic Kidney Cancers
Centre Antoine Lacassagne 60
Early research (Phase 1)Study completedNCT01307267
What this trial is testing

PF-05082566 As A Single Agent And In Combination With Rituximab

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+4 more
Pfizer 190
Early research (Phase 1)Active Not RecruitingNCT01590069
What this trial is testing

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LungMetastatic MelanomaMetastatic Osteosarcoma+5 more
M.D. Anderson Cancer Center 70
Not applicableLooking for participantsNCT06724159
What this trial is testing

Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.

Who this might be right for
Genitourinary Cancers
Spanish Oncology Genito-Urinary Group 500
Not applicableUnknownNCT06424080
What this trial is testing

Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors.

Who this might be right for
Renal Cell Carcinoma
Menoufia University 20
Early research (Phase 1)Ended earlyNCT00816686
What this trial is testing

The Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer

Who this might be right for
Carcinoma, Renal CellKidney NeoplasmsKidney Diseases
Astellas Pharma Inc 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT05468697
What this trial is testing

Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 60
Not applicableLooking for participantsNCT04823923
What this trial is testing

Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer

Who this might be right for
Kidney Neoplasm
Institut du Cancer de Montpellier - Val d'Aurelle 60
Early research (Phase 1)Looking for participantsNCT07128680
What this trial is testing

Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+3 more
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00126503
What this trial is testing

Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Chromophobe Renal Cell CarcinomaClear Cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+3 more
National Cancer Institute (NCI) 73
Not applicableEnded earlyNCT02747173
What this trial is testing

Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques

Who this might be right for
Renal Cell Carcinoma
Spanish Oncology Genito-Urinary Group 4
Testing effectiveness (Phase 2)Study completedNCT00005851
What this trial is testing

Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
Fred Hutchinson Cancer Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT07175480
What this trial is testing

PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Renal Cell Carcinoma (mRCC)
Jinling Hospital, China 30
Testing effectiveness (Phase 2)Study completedNCT00126490
What this trial is testing

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Recurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00004890
What this trial is testing

Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer

Who this might be right for
Drug ExtravasationKidney Cancer
BioMedicines
Testing effectiveness (Phase 2)Looking for participantsNCT05319015
What this trial is testing

Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus

Who this might be right for
Renal Cell Carcinoma
University of Texas Southwestern Medical Center 30
Not applicableStudy completedNCT02411968
What this trial is testing

Follow up After Cryoablation of Small Renal Masses.

Who this might be right for
Carcinoma, Renal Cell
Radboud University Medical Center 9
Post-approval studies (Phase 4)Study completedNCT03514550
What this trial is testing

Effects of Anesthesia on Immunity in Cancer

Who this might be right for
SurgeryRenal Cancer
Meshalkin Research Institute of Pathology of Circulation 20
Not applicableStudy completedNCT02370290
What this trial is testing

Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer

Who this might be right for
Renal Cell Carcinoma
University of Southern California 74
Not applicableStudy completedNCT01773655
What this trial is testing

Clinical and Histopathologic Characteristics of BAP1 Mutations

Who this might be right for
Malignant Pleural Mesothelioma (MPM)Choroidal NevusPrimary Uveal Melanoma (UM)+3 more
Memorial Sloan Kettering Cancer Center 196
Next Page